• About us
  • People
    • 1 st funding period
  • Projects
    • 1 st funding period
  • Open Positions
  • Publications
  • Seminars

Xie, Z; Protzer, U (2024) Activating adaptive immunity by bispecific, T-cell engager antibodies bridging infected and immune-effector cells is a promising novel therapy for chronic hepatitis B

by TUMbrandherde | Jun 4, 2025

Curion, F; Theis, FJ (2024) Machine learning integrative approaches to advance computational immunology

by TUMbrandherde | Jun 4, 2025

Wan, XS; Wisskirchen, K; Jin, T; Yang, L; Wang, XR; Wu, XA; Liu, F; Wu, Y; Ma, C; Pang, Y; Li, Q; Zhang, K; Protzer, U; Du, SD (2024) Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting

by TUMbrandherde | Jun 4, 2025

Next Entries »

Recent Posts

  • LETSimmun enters its second funding period!
  • Joint publication by Matthias Feige and Kathrin Schumann
  • Joint publication by Ulrike Protzer and Matthias Feige
  • New publication of Marion Subklewe in Cancer Immunology Research
  • New publication by Veit Buchholz in nature

Recent Comments

  1. A WordPress Commenter on New publication on cytotoxic T cells in SARS-CoV2 infection
  • Contact
  • About Letsimmun
  • News
  • Open Positions
  • Follow
  • Follow
  • Privacy
  • Imprint
Developed by Sitegeek